Front. Pharmacol.
Frontiers in Pharmacology
Front. Pharmacol.
1663-9812
Frontiers Media S.A.
1382529
10.3389/fphar.2024.1382529
Pharmacology
Correction
Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
Abdelhady et al.
10.3389/fphar.2024.1382529
Abdelhady
Rasha
1
Saber
Sameh
2
*
Abdel-Reheim
Mustafa Ahmed
3
4
*
Mohammad S. Alamri
Mohannad
5
Alfaifi
Jaber
6
Adam
Masoud I. E.
7
Saleh
Lobna A.
8
9
Farag
Azza I.
10
Elmorsy
Elsayed A.
11
12
El-Wakeel
Hend S.
13
14
Doghish
Ahmed S.
15
16
Shaker
Mohamed E.
17
Hazem
Sara H.
18
Ramadan
Heba A.
19
Hamad
Rabab S.
20
21
Mohammed
Osama A.
8
22
*
1
Pharmacology and Toxicology Department, Faculty of Pharmacy, Fayoum University, Fayoum, Egypt
2
Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt
3
Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia
4
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni Suef, Egypt
5
Department of Family Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia
6
Department of Child Health, College of Medicine, University of Bisha, Bisha, Saudi Arabia
7
Department of Medical Education and Internal Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia
8
Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
9
Department of Pharmacology and Toxicology, Collage of Pharmacy, Taif University, Taif, Saudi Arabia
10
Department of Human Anatomy and Embryology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
11
Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia
12
Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
13
Physiology Department, Benha Faculty of Medicine, Benha University, Banha, Egypt
14
Physiology Department, Al-baha Faculty of Medicine, Al-baha University, AlBaha, Saudi Arabia
15
Department of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Cairo, Egypt
16
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt
17
Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia
18
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
19
Department of Microbiology and Immunology, Faculty of Pharmacy, Delta University for Science and Technology, Al Mansurah, Egypt
20
Biological Sciences Department, College of Science, King Faisal University, Al Ahsa, Saudi Arabia
21
Central Laboratory, Theodor Bilharz Research Institute, Giza, Egypt
22
Department of Clinical Pharmacology, College of Medicine, University of Bisha, Bisha, Saudi Arabia
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Sameh Saber, sampharm81@gmail.com; Mustafa Ahmed Abdel-Reheim, m.ahmed@su.edu.sa; Osama A. Mohammed, oamohamed@ub.edu.sa
13
03
2024
2024
15
1382529
05
02
2024
07
02
2024
Copyright © 2024 Abdelhady, Saber, Abdel-Reheim, Mohammad S. Alamri, Alfaifi, Adam, Saleh, Farag, Elmorsy, El-Wakeel, Doghish, Shaker, Hazem, Ramadan, Hamad and Mohammed.
2024
Abdelhady, Saber, Abdel-Reheim, Mohammad S. Alamri, Alfaifi, Adam, Saleh, Farag, Elmorsy, El-Wakeel, Doghish, Shaker, Hazem, Ramadan, Hamad and Mohammed
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis by Abdelhady R, Saber S, Ahmed Abdel-Reheim M, Mohammad S. Alamri M, Alfaifi J, I. E. Adam M, A. Saleh L, I. Farag A, A. Elmorsy E, S. El-Wakeel H, S. Doghish A, E. Shaker M, H. Hazem S, A. Ramadan H, S. Hamad R and A. Mohammed O (2023). Front. Pharmacol. 14:1239025. doi: 10.3389/fphar.2023.1239025
ulcerative colitis
β-hydroxybutyrate
NLRP3 inflammasome
apoptosis
pyroptosis
section-at-acceptance
Inflammation Pharmacology
In the published article, there was an error in affiliations 11 and 12. Instead of:
“11Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”
“12Pharmacology and Therapeutics Department, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”
it should be:
“11Department of Pharmacology and Therapeutics, Qassim College of Medicine, Qassim University, Buraydah, Saudi Arabia.”
“12Department of Clinical Pharmacology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.